Tsung‐Chih Chen

620 total citations
27 papers, 550 citations indexed

About

Tsung‐Chih Chen is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, Tsung‐Chih Chen has authored 27 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Toxicology and 10 papers in Organic Chemistry. Recurrent topics in Tsung‐Chih Chen's work include Bioactive Compounds and Antitumor Agents (11 papers), Cancer therapeutics and mechanisms (9 papers) and Synthesis and biological activity (8 papers). Tsung‐Chih Chen is often cited by papers focused on Bioactive Compounds and Antitumor Agents (11 papers), Cancer therapeutics and mechanisms (9 papers) and Synthesis and biological activity (8 papers). Tsung‐Chih Chen collaborates with scholars based in Taiwan and Russia. Tsung‐Chih Chen's co-authors include Hsu‐Shan Huang, Chia-Chung Lee, Chun‐Liang Chen, Deh‐Ming Chang, Jing‐Jer Lin, Kuo-Feng Huang, Ahmed Ali, Jih‐Hwa Guh, Dah‐Shyong Yü and Fei-Lan Liu and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Tsung‐Chih Chen

27 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsung‐Chih Chen Taiwan 16 328 219 133 125 49 27 550
Chia-Chung Lee Taiwan 16 298 0.9× 196 0.9× 108 0.8× 114 0.9× 39 0.8× 24 494
Chia-Ning Yang Taiwan 12 380 1.2× 274 1.3× 158 1.2× 68 0.5× 90 1.8× 14 668
Sung Yun Cho South Korea 15 356 1.1× 277 1.3× 115 0.9× 43 0.3× 32 0.7× 43 673
Tsann-Long Su Taiwan 19 398 1.2× 493 2.3× 97 0.7× 74 0.6× 38 0.8× 22 733
Sotiris S. Nikolaropoulos Greece 16 336 1.0× 328 1.5× 105 0.8× 43 0.3× 67 1.4× 49 637
Kazuhiro Fukasawa Japan 11 345 1.1× 183 0.8× 203 1.5× 63 0.5× 23 0.5× 19 538
Laura Dal Bo Italy 16 368 1.1× 220 1.0× 201 1.5× 36 0.3× 59 1.2× 20 724
Yali Deng China 9 479 1.5× 236 1.1× 240 1.8× 43 0.3× 73 1.5× 13 802
Marek Šarišský Slovakia 15 245 0.7× 129 0.6× 49 0.4× 40 0.3× 46 0.9× 25 530
Yong‐Cheng Ma China 13 275 0.8× 344 1.6× 53 0.4× 43 0.3× 32 0.7× 19 630

Countries citing papers authored by Tsung‐Chih Chen

Since Specialization
Citations

This map shows the geographic impact of Tsung‐Chih Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsung‐Chih Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsung‐Chih Chen more than expected).

Fields of papers citing papers by Tsung‐Chih Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsung‐Chih Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsung‐Chih Chen. The network helps show where Tsung‐Chih Chen may publish in the future.

Co-authorship network of co-authors of Tsung‐Chih Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Tsung‐Chih Chen. A scholar is included among the top collaborators of Tsung‐Chih Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsung‐Chih Chen. Tsung‐Chih Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeh, Su‐Peng, Jyh‐Pyng Gau, Po‐Nan Wang, et al.. (2021). High rate of invasive fungal infections after non-T cell depleted haploidentical allo-HSCT even under antifungal prophylaxis. Bone Marrow Transplantation. 56(7). 1750–1753. 5 indexed citations
2.
Chen, Tsung‐Chih, et al.. (2016). TC-N19, a novel dual inhibitor of EGFR and cMET, efficiently overcomes EGFR-TKI resistance in non-small-cell lung cancer cells. Cell Death and Disease. 7(6). e2290–e2290. 33 indexed citations
3.
Ali, Ahmed, Yu-Ru Lee, Tsung‐Chih Chen, et al.. (2016). Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets Determination. PLoS ONE. 11(4). e0154278–e0154278. 16 indexed citations
4.
Lee, Chia-Chung, Chun‐Liang Chen, Fei-Lan Liu, et al.. (2016). Development of 1‐Amino‐4‐(phenylamino)anthraquinone‐2‐sulfonate Sodium Derivatives as a New Class of Inhibitors of RANKL‐Induced Osteoclastogenesis. Archiv der Pharmazie. 349(5). 342–355. 5 indexed citations
5.
Lee, Chia-Chung, Ling‐Jun Ho, Jenn-Haung Lai, et al.. (2016). A New Application of Parallel Synthesis Strategy for Discovery of Amide-Linked Small Molecules as Potent Chondroprotective Agents in TNF-α-Stimulated Chondrocytes. PLoS ONE. 11(3). e0149317–e0149317. 6 indexed citations
6.
Lee, Chia-Chung, Fei-Lan Liu, Chun‐Liang Chen, et al.. (2015). Discovery of 5-(2′,4′-difluorophenyl)-salicylanilides as new inhibitors of receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis. European Journal of Medicinal Chemistry. 98. 115–126. 32 indexed citations
7.
Chen, Tsung‐Chih, Chun‐Liang Chen, Chia-Chung Lee, et al.. (2015). Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation. Oncotarget. 7(42). 67986–68001. 10 indexed citations
8.
Lee, Chia-Chung, Fei-Lan Liu, Chun‐Liang Chen, et al.. (2015). Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones. Bioorganic & Medicinal Chemistry. 23(15). 4522–4532. 22 indexed citations
9.
Lee, Yu-Ru, Tsung‐Chih Chen, Chia-Chung Lee, et al.. (2015). Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents. European Journal of Medicinal Chemistry. 102. 661–676. 30 indexed citations
10.
Chen, Tsung‐Chih, et al.. (2014). Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents. European Journal of Medicinal Chemistry. 103. 615–627. 32 indexed citations
11.
Pan, Chun, Ming‐Jyh Sheu, Wen‐Hsin Lin, et al.. (2014). NSC746364, a G-Quadruplex-Stabilizing Agent, Suppresses Cell Growth of A549 Human Lung Cancer Cells Through Activation of the ATR/Chk1-Dependent Pathway. Journal of Pharmacological Sciences. 124(1). 7–17. 10 indexed citations
12.
Chen, Chun‐Liang, Fei-Lan Liu, Chia-Chung Lee, et al.. (2014). Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents. European Journal of Medicinal Chemistry. 87. 30–38. 18 indexed citations
13.
Chen, Tsung‐Chih, Dah‐Shyong Yü, Kuo-Feng Huang, et al.. (2013). Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents. European Journal of Medicinal Chemistry. 69. 278–293. 23 indexed citations
14.
Lee, Chia-Chung, Deh‐Ming Chang, Kuo-Feng Huang, et al.. (2013). Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties. Bioorganic & Medicinal Chemistry. 21(22). 7125–7133. 23 indexed citations
15.
Chen, Chun‐Liang, Deh‐Ming Chang, Tsung‐Chih Chen, et al.. (2012). Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology. European Journal of Medicinal Chemistry. 60. 29–41. 36 indexed citations
16.
Lee, Chia-Chung, Kuo-Feng Huang, Deh‐Ming Chang, et al.. (2012). Design, synthesis and evaluation of telomerase inhibitory, hTERT repressing, and anti-proliferation activities of symmetrical 1,8-disubstituted amidoanthraquinones. European Journal of Medicinal Chemistry. 50. 102–112. 24 indexed citations
17.
Huang, Kuo‐Feng, et al.. (2011). Synthesis, Telomerase Evaluation and Anti‐Proliferative Studies on Various Series of Diaminoanthraquinone‐Linked Aminoacyl Residue Derivatives. Archiv der Pharmazie. 345(2). 101–111. 6 indexed citations
18.
Lee, Chia-Chung, Kuo-Feng Huang, Pen-Yuan Lin, et al.. (2011). Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives. European Journal of Medicinal Chemistry. 47(1). 323–336. 26 indexed citations
19.
Lin, Yu‐Sheng, et al.. (2011). Different roles of p53 in the regulation of DNA damage caused by 1,2-heteroannelated anthraquinones and doxorubicin. The International Journal of Biochemistry & Cell Biology. 43(12). 1720–1728. 28 indexed citations
20.
Huang, Hsu‐Shan, Tsung‐Chih Chen, Kuo-Feng Huang, et al.. (2009). Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[1,2-d]imidazole-6,11-dione homologues. Bioorganic & Medicinal Chemistry. 17(21). 7418–7428. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026